Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. - Wikidata - wikimedia - TriplyDB

Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults.

Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults.

http://www.wikidata.org/entity/Q44746948

about

Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.Risk factors for late-life cognitive decline and variation with age and sex in the Sydney Memory and Ageing Study Amyloid burden and neural function in people at risk for Alzheimer's Disease.Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults.Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's disease Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.The preclinical Alzheimer cognitive composite: measuring amyloid-related decline Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease.Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging.Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.Meta-analysis of amyloid-cognition relations in cognitively normal older adults Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score.Fibrillar amyloid correlates of preclinical cognitive decline.Nonvascular retinal imaging markers of preclinical Alzheimer's disease.Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis.Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults.Enabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: an update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study.Amyloid imaging in Alzheimer's disease: a literature review.Amyloid deposition in semantic dementia: a positron emission tomography study.[Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status.Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases.Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.Discrete pools of oligomeric amyloid-β track with spatial learning deficits in a mouse model of Alzheimer amyloidosis.KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden.Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia.Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.The Association of Apolipoprotein E Gene Polymorphism With Cognitive Performance in Nondemented Polish Adults Aged 55 to 75.

P2860

Q30996727-6F39E0F4-753A-4B6A-8230-E7F85D809D5F Q31120480-BB2EF6D6-3510-46B2-BB8E-20C451C5688A Q33599047-8BB95476-E9CE-4A45-8A6D-429C2EAB30B7 Q33672569-D37BEEF3-169A-4A11-A827-0E79B232288A Q33775095-CCA28FD5-B02D-48FA-BB64-1575ED243458 Q33872248-DB7E03AE-8613-43CC-9BC7-D3DC5E7C7B70 Q33920450-FDD45D83-75CC-471E-A928-F805D8760C46 Q34180413-A40B3047-138B-4C82-AD09-424C4B27D1DE Q34333511-85320B7E-4D6F-4CC9-A144-1E4172B36EE4 Q34422469-B8EB1BF6-551E-4B8B-A10F-6729984E800F Q34728987-C11724A9-E5E4-47C0-96B5-4F3B4D071910 Q34756558-2EB2116D-4522-4379-AED3-C407E4BADE83 Q35229601-305FFE9C-564D-4B4F-B744-C5BBE16F940E Q35598271-405A805A-25FA-4D8C-8731-F630ACA3961C Q35722468-73AAE9EA-BD61-45EF-BB74-EF0E408B03E4 Q35796631-1DF9DD9D-F841-4AB3-B347-936349A47F1A Q36005633-725190CF-53E7-41A6-BC60-1D44A37EE325 Q36456068-1ADC79C9-C64F-4D2E-9533-F7E578BB1AFD Q36510006-A7F0F94A-B841-432A-A279-6297F7CF0F75 Q36594552-7FEFDB17-11C0-45A3-BF65-D601C7706576 Q36850873-697BB75D-1314-4706-A1AE-3756FEB69255 Q36934154-016D2454-56CF-417B-AD45-786ED9959792 Q37018071-C0A5E59C-F161-4DE5-9B1E-524C2A11E480 Q37363628-C0DF9609-1E3A-4DE0-9410-182C40806A7A Q37650253-51585645-ACC6-48BA-81D0-2CFF40F6ED03 Q37689697-CB16D1F9-1EF4-4263-B6B1-E6DAE6D75B9D Q37698159-1DD1A567-060F-48CF-AA7B-4E0D58432367 Q38178373-7A471225-A1E1-4E67-BE93-F514999B79FA Q38250091-6359830B-DDEF-470B-B14B-4DF18355EE31 Q38396800-0C3E38D9-F70F-46C3-84F0-6EF77D2A0729 Q40547789-FD762FB9-6C6B-4957-98D2-E71D92B3E60C Q42328545-AABB966F-4694-48AD-98C8-51D943FF8F46 Q44901723-2FD6A52A-3944-4FFD-91DE-C28CAD807254 Q46238269-0B633EBF-008B-467D-9BF1-10CD9706930C Q47549663-ABA17D96-8F1B-4BF9-BF8F-1758A3C31B23 Q47947750-C40ECAC7-AFFF-4052-BAEC-2E21AA3B2181 Q48126599-039376C3-1BCC-42A0-B377-25AE11CE3107 Q48426336-036491ED-7C4D-4429-AEC4-EB36275D1F00 Q48503003-A740C92E-CC80-4C71-A5D0-72482551217C Q50564711-4842DDF5-A84D-4FC4-B30C-1279B78E4CA4

P2860

Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults.

http://www.wikidata.org/entity/Q44746948

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Stronger effect of amyloid loa ...... cline in healthy older adults.

@en

Stronger effect of amyloid loa ...... cline in healthy older adults.

@nl

type

label

Stronger effect of amyloid loa ...... cline in healthy older adults.

@en

Stronger effect of amyloid loa ...... cline in healthy older adults.

@nl

prefLabel

Stronger effect of amyloid loa ...... cline in healthy older adults.

@en

Stronger effect of amyloid loa ...... cline in healthy older adults.

@nl

P1433

Q44746948-EDF858B4-51D0-452A-AE35-DE1126398DAE

P1476

Q44746948-AC194206-8C7D-4EFF-A7EA-DF8E65C6299A

P2093

Q44746948-1CDBE49A-3AC3-4554-B0FE-24E05A9CB05B

Q44746948-3AA4141B-289D-4A5F-999A-8E26E5836C63

Q44746948-56CCFE89-BFF9-4835-9F3B-3BC1D2E90B85

Q44746948-A4FE8C8A-69FA-4266-914C-0203FC0C146C

Q44746948-AEC52A47-3850-4A62-BE1F-B6CB1EBD5173

Q44746948-B2B8ED6E-22DD-419D-BF27-8A86236745A9

Q44746948-D7840A0D-B8C1-4833-8EAC-0185B742720B

Q44746948-DA2CDB34-817A-40EA-9ED0-962828A3D4A4

P304

Q44746948-DF44893F-C47E-41A7-8B7D-85860CFA1F47

P31

Q44746948-DDA9D8D6-98C0-492C-B049-C23C42CD1037

P356

Q44746948-511C7859-141C-4196-8766-F793808581E6

P407

Q44746948-FE675483-A256-48DF-82D6-9380A8C1DADB

P433

Q44746948-8706C42C-0D14-4388-9160-E7EF5CA9DF6F

P478

Q44746948-6D1E65C4-FBBF-45F6-8853-B3BA0D3C2366

P50

Q44746948-0351FADB-A132-4C6C-9C28-18C23F7C6B5C

Q44746948-1F59FF48-4BE8-446D-ABFF-ACAEB357CC0C

Q44746948-5BA786B4-D9E0-4462-BEE5-A7DF12C2A912

Q44746948-80BDF471-1F1A-48C3-82B6-D05F6A6D384B

Q44746948-ABE9DC3B-2360-4317-A97F-AB6F91F58B76

Q44746948-FE065451-61D3-4B05-8096-7AE26460C38D

P577

Q44746948-B31CF110-A258-407B-A9EC-8D4921D4780A

P698

Q44746948-40A03432-34E3-40C1-BDAE-671D583943E0

P356

WNL.0B013E31826E9AE6

P1433

P1476

Stronger effect of amyloid loa ...... cline in healthy older adults.

@en

P2093

AIBL Research Group

http://www.w3.org/2001/XMLSchema#string

Christopher Rowe

http://www.w3.org/2001/XMLSchema#string

David Ames

http://www.w3.org/2001/XMLSchema#string

David Darby

http://www.w3.org/2001/XMLSchema#string

Karra Harrington

http://www.w3.org/2001/XMLSchema#string

Robert H Pietrzak

http://www.w3.org/2001/XMLSchema#string

Victor L Villemagne

http://www.w3.org/2001/XMLSchema#string

Yen Ying Lim

http://www.w3.org/2001/XMLSchema#string

P304

1645-1652

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E31826E9AE6

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Colin L. Masters

Cassandra Szoeke

Kathryn A Ellis

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23071163

http://www.w3.org/2001/XMLSchema#string